Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Merck Generics Company Intelligence Report' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Generic Option; The |
July 2006 | £440 | 50 % |
|
Pharma R&D Fact Book, The 2006 |
November 2007 | £495 | 38.5 % |
|
Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in The Face of Growing Generic Competition |
July 2008 | £3800 | 35 % |
|
United States Pharmaceuticals and Healthcare Report Q3 2006 |
July 2006 | £395 | 29.5 % |
|
The Cardiovascular Disorders Market Outlook to 2012 |
February 2008 | £1995 | 25.5 % |
|
Spain Pharmaceuticals & Healthcare |
July 2006 | £395 | 24 % |
|
The Japanese Pharmaceutical Market Outlook to 2014 Policy environment, market structure, competitive landscape, growth opportunities |
January 2010 | £3835 | 23 % |
|
The Global HIV/Aids Market Outlook To 2012 |
July 2007 | £1495 | 22 % |
|
The Cancer Market Outlook To 2014 Competitive landscape, market size, pipeline analysis and growth opportunities |
January 2010 | £3835 | 20 % |
|
Biosimilars: a viable market? |
September 2008 | £1295 | 19.6 % |
|
Diabetes Drug Pipeline Competitor Analysis |
November 2008 | £1045 | 14.5 % |
